to convert atrial fibrillation 19 patients ( 8 male and 11 female ) were administered ( 5-vinyl-2-quinuclidinyl ) - ( 6-methoxy-4-quinolyl ) -methanol , a new slow-release quinidine formulation ( chinidinorm ) , containing 250 mg quinidine bisulphate x 4 h2o per tablet , corresponding to 200 mg quinidine sulphate or 164 mg quinidine base respectively .
C0004238
atrial fibrillation
C0034414
quinidine